Scottish Neurological Research Fund Announcement

 

Earlier this year, the Scottish Neurological Research Fund (SNRF) launched a second round of funding, following its success in 2019.

The scheme provides up to £15,000 of funding per application for small innovative projects investigating the cause, prevention, treatment and/or management of neurodegenerative or neurodevelopmental disorders. To encourage the development of collaborative networks, all projects need to involve at least 2 academic centres.

The SNRF is financially supported by RS Macdonald, the Chief Scientist Office and administered by the University of St Andrews

The quality of applications was extremely high, and we are delighted to announce the successful recipients of this award. The portfolio of research includes basic science, clinical and qualitative approaches aimed at better understanding conditions including Parkinson’s, Motor Neurone Disease and Alzheimer’s Disease. Please see the full list and projects below:

Name

Institution

Project Title

Aneesha Sil

University of Aberdeen

Do iron-oxide nanoparticles contribute to Parkinson’s Disease pathology?

Martin Taylor-Rowan

University of Glasgow

 

Exploring the association between physical frailty, brain frailty and long-term cognition

Sarah Gregory

University of Edinburgh

Cortisol mediated cardiovascular risk factors for dementia and other neurological conditions

Matthew Broadhead

University of St Andrews

 

Investigating Synaptic Dysfunction & TDP43

Pathology in Amyotrophic Lateral Sclerosis

Using a Synaptosome Imaging Assay

Helena Chaytow

University of Edinburgh

Repurposing terazosin for ALS: how treatment changes the proteome in a TDP-43 mouse model

Aileen Wong

Glasgow Caledonian University

Effects of a TSPO ligand on cholesterol homeostasis in an Alzheimer’s disease mouse model

Mizuki Morisaki

University of St Andrews

Alpha-amylase: a potential therapeutic target for Alzheimer’s Disease

Stina Saunders

University of Edinburgh

Development of the electronic Person Specific Outcome measure (ePSOM) app: A technological solution for an outcome measure used in the Alzheimer’s disease trials and practice

Eileen Harkness-Murphy

Alzheimer Scotland Centre for Policy and Practice, University of the West of Scotland (UWS)

 

Trauma Informed Approach in Dementia (TrIAD): Understanding trauma within family based dementia care: an analysis of Telephone Helpline Calls

 

 

 

Congratulations to all the researchers who received awards. We look forward to following on with your progress. 

If you are a researcher, you can keep up to date with all the latest funding and career opportunities in Scotland here. Also make sure to follow the SDRC on Twitter. 

 

 

Read more SDRC Latest

Alzheimer Scotland welcomes announcement of Scottish Brain Health Register

Scotland’s largest annual dementia conference (Friday 8 June, EICC, Edinburgh) will see the official launch of the newly created Scottish Brain Health Register. The register is led by the Scottish Dementia Informatics Platform (part of the...

Edinburgh Dementia Prevention Summer School 2022

Edinburgh Dementia Prevention are hosting a brain health summer school on Monday 26 September - Thursday 29 September 2022, at St Leonard's Hall, Edinburgh. It is is a 4-day interactive course designed principally for trainee and qualified clinicians, nurses and...

Alzheimer Disease International Clinician Survey

This year Alzheimer's Disease International has commissioned McGill University, Montreal, Canada to produce this year's World Alzheimer Report on diagnosis, as well as the 2022 World Alzheimer Report on post-diagnostic support. The first of three surveys is now ready...

National Workshops- Patient Public Involvement

NHS Research Scotland (NRS) has funded a small bid from the Universities of Edinburgh, Aberdeen, Dundee and Glasgow to run some Patient Public Involvement (PPI) Workshops. The idea of the workshops is to have a collective dialogue about how we progress PPI in...

SDRC Report: How COVID-19 has impacted research

We have produced a report based on the findings of how COVID-19 has impacted our members’ research- with particular focus on ECRs

Neuroprogressive and Dementia Research Network Conference 2022

This year's Neuroprogressive and Dementia Network (from NHS Research Scotland) Annual Conference will be day focused on those most impacted by research outcomes, and an opportunity to learn from their experiences to improve the research landscape. It will bring...

Aducanumab: Approval of new Alzheimer’s disease drug explained

Aducanumab: Dr Terry Quinn explains approval of new Alzheimer's disease drug  SDRC Executive Committee member, Dr Terry Quinn, Terry takes us through all the important facts behind the recent announcement by the FDA in the US to approve aducanumab for the treatment of...

Professor John Starr: A tribute

We're deeply saddened to hear that Professor John Starr has passed away. Prof Starr supported our work for many years as an Alzheimer Scotland Trustee, and as the Director of the Alzheimer Scotland Dementia Research Centre at the University of Edinburgh....

Announcement of the Brain Health Alliance for Research Challenge

The SDRC are excited to be part of a new collaborative research alliance, supported by the Scottish Funding Council.  The Scottish Brain Health Alliance for Research Challenge (ARC) is a project that will receive up to £600,000 to create multi-disciplinary,...

NHS Research Scotland Neuroprogressive and Dementia Research Network Strategy Launch

On 3rd December 2021, the NHS Research Scotland Neuroprogressive and Dementia Research Network (NRS NDN) launched a new strategy.  It sets out the Network's intention to involve, engage with, and support people with lived experience of neuroprogressive conditions or...